Protective and Potential Reparative Mechanisms of Prinsepia utilis Seed Oil on the Skin Barrier: Fatty Acid Composition, Epidermal Lipid Metabolism, and Research Evidence
Protective and Potential Reparative Mechanisms of Prinsepia utilis Seed Oil on the Skin Barrier: Fatty Acid Composition, Epidermal Lipid Metabolism, and Research Evidence
Introduction
Prinsepia utilis seed oil is a plant-derived oil obtained from the seeds of Prinsepia utilis Royle, a member of the Rosaceae family. Its cosmetic ingredient name is generally listed as Prinsepia Utilis Seed Oil. It consists primarily of triacylglycerols, with linoleic acid, oleic acid, palmitic acid, and stearic acid as its major fatty acids.
The effects of P. utilis seed oil on the skin barrier can be considered at three levels:
① It forms an emollient oil film on the skin surface, thereby slowing water evaporation;
② It supplies exogenous fatty acids, such as linoleic acid, which may serve as partial substrates for epidermal lipid metabolism;
③ In cell-based and reconstructed skin models, it has shown preliminary effects on keratinocyte differentiation, cornified envelope formation, and inflammatory responses.
The fact that P. utilis grows in high-altitude environments does not mean that its oil can directly confer the plant’s cold tolerance or ultraviolet resistance to human skin. Its skincare value must instead be evaluated on the basis of its lipid composition, its potential involvement in cutaneous lipid metabolism, and the structural changes observed in the epidermis.
1. Source and Chemical Composition of Prinsepia utilis Seed Oil
1.1 Differences Between P. utilis Seed Oil and Other P. utilis-Derived Materials
P. utilis seeds can be processed by mechanical pressing, solvent extraction, or subcritical extraction to obtain a lipid-rich seed oil. The residual oil cake produced after oil extraction contains polysaccharides, proteins, and other water-soluble constituents.
Materials derived from different parts or fractions of P. utilis differ in both chemical composition and mechanism of action.
Material | Major Components | Main Research Focus |
P. utilis seed oil | Triacylglycerols; small amounts of phospholipids, glycolipids, sterols, tocopherols, and other unsaponifiable constituents | Emolliency, fatty acid supply, barrier protection, and modulation of inflammation |
Aqueous extract of P. utilis oil cake | Polysaccharides, proteins, and other polar compounds | Keratinocyte differentiation and expression of lipid-synthesizing enzymes and tight-junction proteins |
P. utilis polysaccharides | Isolated and purified polysaccharide fractions | Peroxisome proliferator-activated receptor-α-related signaling and Claudin protein expression |
Extracts of P. utilis leaves or fruit shells | Flavonoids, terpenoids, polyphenols, and related compounds | Antioxidant, anti-inflammatory, and other plant bioactivity studies |
1.2 Lipid Composition of P. utilis Seed Oil
The principal components of P. utilis seed oil are triacylglycerols (TAGs), which are neutral lipids formed when one glycerol molecule is linked to three fatty acids through ester bonds:
Glycerol + 3 fatty acids ⇌ triacylglycerol + 3H₂O
Lipidomic studies have also detected phospholipids, glycolipids, and multiple glyceride species in P. utilis seed oil. Extraction and refining methods may alter the composition of terpenoids, steroids, quinones, and other minor compounds in addition to affecting the fatty acid profile.
The fatty acid proportions in P. utilis seed oil vary according to plant genetic source, geographic origin, degree of ripeness, extraction method, and refining intensity. The table below presents two representative analytical results from Chinese and Indian Himalayan samples. Because the studies used different raw materials and analytical methods, the values are intended only to illustrate inter-sample variability and should not be regarded as a fixed composition for P. utilis seed oil.
Fatty Acid | Representative Value in a Chinese Sample | Indian Himalayan Sample | Relevance to the Skin Barrier |
Oleic acid, C18:1 | 38.82% | 28.11% | Improves emolliency and spreadability; high concentrations of free oleic acid may increase stratum corneum lipid fluidity |
Linoleic acid, C18:2 | 37.15% | 59.06% | An essential fatty acid and an important structural substrate for linoleate-containing acylceramides |
Palmitic acid, C16:0 | 15.15% | 9.51% | The major primary product of de novo fatty acid synthesis in the epidermis and a precursor that can be elongated into longer-chain fatty acids |
Stearic acid, C18:0 | 6.85% | 3.32% | Enhances oil body, film stability, and a degree of occlusivity |
α-Linolenic acid, C18:3 | 1.13% | Not separately reported | Generally present at low levels and relatively susceptible to oxidation |
Greater variation in the proportions of saturated, monounsaturated, and polyunsaturated fatty acids has been observed among different plant populations in the western Himalayas. Overall, these data indicate that oleic acid and linoleic acid are generally the predominant fatty acids in P. utilis seed oil.
1.3 Skincare Significance of the Four Major Fatty Acid Classes
1.3.1 Linoleic Acid: A Key Exogenous Substrate for Barrier Lipids
Linoleic acid is an essential fatty acid that cannot be synthesized de novo by the human body. Certain specialized epidermal ceramides require linoleic acid to be esterified to the terminal ω-hydroxyl group of an ultra-long-chain fatty acid, thereby forming ω-O-acylceramides.
These acylceramides contribute to the formation of:
① The intercellular lipid lamellae of the stratum corneum;
② The corneocyte lipid envelope;
③ Low-permeability lipid structures within the epidermis.
In P. utilis seed oil, linoleic acid is primarily esterified within triacylglycerols. Before it can potentially enter epidermal lipid metabolism, it must be released, taken up by cells, activated to fatty acyl-CoA, and re-esterified. Therefore, P. utilis seed oil serves as a reservoir of linoleic acid rather than as a direct source of preformed acylceramides.
1.3.2 Oleic Acid: Improved Spreadability with Potential Effects on Lipid Fluidity
Oleic acid contains one cis double bond, which introduces a bend into the carbon chain and increases oil fluidity and spreadability on the skin.
At high concentrations, free oleic acid may insert into the lipid lamellae of the stratum corneum, disrupt the orderly packing of hydrocarbon chains, and increase the penetration of substances through the skin. Most of the oleic acid in P. utilis seed oil is esterified in triacylglycerols, and its effects cannot be equated with those observed experimentally using high concentrations of free oleic acid.
The proportion of free oleic acid may increase when the acid value of the raw material rises or when lipid hydrolysis occurs. Consequently, formulation-related risks associated with oleic acid depend mainly on the extent of oil hydrolysis, the use level, the oxidation status of the oil, and the overall emulsion structure.
1.3.3 Palmitic Acid and Stearic Acid: Sources of Saturated Fatty Acid Substrates
Palmitic acid is the principal product generated by fatty acid synthase and can be further elongated by fatty acid elongases to produce longer-chain fatty acids. Stearic acid has a relatively straight saturated carbon chain, which contributes to greater oil-film body and structural stability.
Some free fatty acids and ceramides in the stratum corneum contain long-chain or ultra-long-chain fatty acids with chain lengths of C22 or greater. Because P. utilis seed oil primarily supplies C16 and C18 fatty acids, it cannot directly replace the complete long-chain lipid system of the stratum corneum.
2. Structural Basis for the Effects of P. utilis Seed Oil on the Skin Barrier

2.1 The “Brick-and-Mortar” Structure of the Skin Barrier
The principal permeability barrier of the skin is located in the stratum corneum (SC). An intact epidermal barrier is jointly formed by corneocytes, the cornified envelope, intercellular lipids, and tight junctions in the granular layer.
Barrier Structure | Major Components | Core Function |
Corneocytes | Keratins and filaggrin-related products | Form the main cellular component of the stratum corneum, maintain mechanical strength, and retain intracellular water |
Cornified envelope | Cross-linked proteins such as loricrin and involucrin | Forms a durable protein shell around the exterior of corneocytes |
Intercellular lipids | Ceramides, cholesterol, and free fatty acids | Form ordered lamellar structures that restrict the penetration of water and exogenous substances |
Tight junctions | Claudins, occludin, ZO-1, and related proteins | Regulate paracellular permeability between cells in the granular layer |
P. utilis seed oil may primarily affect two aspects of this barrier:
① It forms an emollient film over the outer surface of the stratum corneum, reducing water diffusion;
② It supplies certain fatty acid substrates and may influence keratinocyte differentiation and lipid metabolism.
However, P. utilis seed oil does not contain the complete combination of ceramides, cholesterol, and long-chain free fatty acids present in the stratum corneum. It therefore cannot independently replace the entire intercellular lipid matrix.
2.2 What Transepidermal Water Loss Reflects
Transepidermal water loss (TEWL) is the rate at which water diffuses from the body through the epidermis into the external environment. When temperature, humidity, and measurement conditions are controlled, an increase in TEWL generally indicates a reduced ability of the epidermis to limit water diffusion.
A reduction in TEWL after application of P. utilis seed oil may arise from two types of effects:
① Immediate Physical Effects
P. utilis seed oil forms a hydrophobic film on the skin surface, lengthening the diffusion path for water moving outward and thereby causing a rapid decrease in measured TEWL.
② Delayed Structural Effects
With continued use, improvements in keratinocyte differentiation, ceramide synthesis, intercellular lipid organization, or tight-junction integrity may produce barrier benefits that partially persist after discontinuation or cleansing of the surface oil film.
An immediate reduction in TEWL mainly reflects surface occlusion. To determine whether structural repair has occurred within the skin itself, additional assessments are required, including TEWL after wash-off, the rate of recovery following barrier disruption, stratum corneum lipid composition, and changes in barrier-related proteins.
3. Principal Mechanisms of Action of P. utilis Seed Oil
3.1 Surface Film Formation: Rapid Reduction of Water Evaporation
After topical application, P. utilis seed oil can fill small irregularities on the surface of the stratum corneum, reduce friction between corneocytes and at the interface between the skin and the external environment, and form a partially emollient oil film over the skin surface.
The process can be summarized as follows:
Spreading of P. utilis seed oil → surface coverage by the oil phase → increased resistance to water-vapor diffusion → reduced TEWL → relief of dryness, tightness, and roughness
This effect does not depend on the synthesis of new proteins or lipids and may therefore occur rapidly. Once the oil film is removed by cleansing, the effect may diminish accordingly.
3.2 Biochemical Basis for the Participation of Linoleic Acid in Acylceramide Synthesis
Epidermal acylceramide synthesis requires several sequential steps, including the generation of ultra-long-chain fatty acids, ω-hydroxylation, ceramide synthesis, and linoleic acid transfer:
Palmitic acid → fatty acid elongases such as ELOVL1 and ELOVL4 → ultra-long-chain fatty acids → CYP4F22-catalyzed ω-hydroxylation → ω-hydroxy fatty acids → ceramide synthase 3 → ω-hydroxyceramides
Patatin-like phospholipase domain-containing protein 1 (PNPLA1) can subsequently transfer linoleic acid from triacylglycerols to ω-hydroxyceramides:
Linoleate-containing triacylglycerol + ω-hydroxyceramide
—PNPLA1→ ω-O-acylceramide + diacylglycerol
The resulting ω-O-acylceramides further contribute to the formation of stratum corneum lipid lamellae and the corneocyte lipid envelope.
This reaction demonstrates the biochemical plausibility that linoleic acid esterified within triacylglycerols may participate in the synthesis of barrier lipids. However, current studies have not fully established the proportion of topically applied linoleic acid from P. utilis seed oil that penetrates the stratum corneum, reaches the viable epidermis, and serves as an actual substrate for PNPLA1. Therefore, the statement that the oil is “rich in linoleic acid” should not be treated as equivalent to evidence that it “increases acylceramide levels.”
3.3 Endogenous Synthesis of Fatty Acids and Cholesterol
Keratinocytes can also synthesize the fatty acids and cholesterol required for the skin barrier through their own metabolic pathways.
3.3.1 Fatty Acid Synthase
Fatty acid synthase (FASN) catalyzes the conversion of acetyl-CoA and malonyl-CoA into palmitic acid.
FASN uses one molecule of acetyl-CoA as the initiating unit and sequentially incorporates seven molecules of malonyl-CoA and fourteen molecules of NADPH through repeated condensation, reduction, and dehydration reactions to generate palmitic acid.
Palmitic acid may subsequently undergo elongation and desaturation to form other fatty acids.
P. utilis seed oil supplies exogenous fatty acids. After entering cells, these fatty acids may influence lipid sensing and metabolic regulation; however, supplying fatty acids does not necessarily increase FASN expression. The clearest evidence that P. utilis-derived materials increase FASN expression has primarily been obtained with aqueous extracts of P. utilis oil cake and purified P. utilis polysaccharides rather than with the seed oil itself.
3.3.2 HMG-CoA Reductase
3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) is an important rate-limiting enzyme in the cholesterol biosynthesis pathway:
HMG-CoA + 2NADPH
—HMGCR→ mevalonate → multiple reactions → cholesterol
Cholesterol is a major component of the intercellular lipid matrix of the stratum corneum and helps regulate the fluidity and phase behavior of lamellar lipid structures.
Evidence of increased HMGCR expression in studies of P. utilis has mainly been obtained from aqueous extracts of the oil cake. In studies of P. utilis polysaccharides, the measured enzyme HMGCS2 was mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2. HMGCS2 is not the same enzyme as HMGCR and cannot be used to demonstrate enhancement of the rate-limiting step in cholesterol synthesis.
3.4 Ceramide Degradation and Acid Ceramidase
Acid ceramidase 1 (ASAH1) primarily catalyzes ceramide hydrolysis within acidic intracellular compartments:
Ceramide + H₂O
—ASAH1→ sphingosine + free fatty acid
The resulting sphingosine can enter the salvage pathway and be converted back into ceramide. Thus, ASAH1 participates in ceramide degradation and recycling rather than in unidirectional ceramide synthesis.
An increase in ASAH1 expression or activity may produce two different outcomes:
① When synthetic capacity is sufficient, it may accelerate ceramide turnover and sphingosine recycling;
② When the rate of degradation exceeds the rate of synthesis, it may cause a net loss of ceramides.
Animal studies have shown that excessive epidermal acid ceramidase activity can reduce stratum corneum ceramide levels and impair water retention and barrier function.
Cell and nude-mouse studies have reported increased ceramide levels in keratinocyte culture supernatants after treatment with P. utilis seed oil, together with enhanced immunohistochemical staining related to acid ceramidase in the skin. However, the study did not measure actual acid ceramidase enzymatic activity, ceramide subclasses, or metabolic flux. It therefore cannot establish that increased acid ceramidase expression was the direct cause of the observed increase in ceramides.
Comprehensive studies of the relationship between P. utilis seed oil and ASAH1, including enzymatic activity, ceramide subclass analysis, and metabolic flux, remain lacking. Accordingly, changes in ASAH1 expression alone cannot demonstrate that total ceramide content or net synthesis of barrier lipids has necessarily increased.
3.5 Keratinocyte Differentiation and Cornified Envelope Formation
Preliminary studies using reconstructed human epidermis models have shown that formulations containing P. utilis seed oil may increase certain markers associated with epidermal differentiation.
These proteins perform distinct functions:
① Filaggrin (FLG) promotes the aggregation of keratin fibers, while its degradation products contribute to the natural moisturizing factor;
② Loricrin (LOR) and involucrin (IVL) form major components of the protein scaffold of the cornified envelope;
③ Transglutaminase 1 (TGM1) cross-links cornified envelope proteins;
④ Ceramide synthase 3 (CERS3) participates in the synthesis of ultra-long-chain ceramides;
⑤ Caspase-14 and bleomycin hydrolase participate in the subsequent processing of FLG and the formation of natural moisturizing factor components.
The functional relationship can be summarized as follows:
Normal keratinocyte differentiation → FLG promotes keratin aggregation → LOR and IVL form the envelope scaffold → TGM1 completes protein cross-linking → CERS3 participates in long-chain ceramide synthesis → corneocyte and intercellular lipid structures become more complete
The relevant study used complete formulations containing 5% or 10% P. utilis seed oil in reconstructed skin models, and the formulation base may also have contributed to the observed effects. At present, the findings can be regarded as preliminary evidence that P. utilis seed oil may support epidermal differentiation and barrier formation. However, they cannot replace human clinical studies designed to distinguish the independent contribution of the oil itself.
3.6 Tight Junctions and Modulation of Inflammation
Claudin-1, occludin, and tight junction protein 1 (TJP1, also known as ZO-1) are important components of epidermal tight junctions. Claudin-1 has a well-established role in regulating paracellular permeability in the granular layer.
A reconstructed epidermis study of P. utilis seed oil reported changes in TJP1 and Claudin-5 expression. Claudin-5 is primarily associated with endothelial tight junctions, and changes observed in epidermal models should therefore be interpreted in conjunction with protein localization and cell-type analysis.
Publicly available evidence that P. utilis seed oil directly increases Claudin-1 remains limited. Findings related to Claudin-1 have mainly been obtained with P. utilis polysaccharides and aqueous extracts of the oil cake.
The same reconstructed epidermis study also observed reductions in interleukin-1α and interleukin-8 in a sodium dodecyl sulfate injury model, as well as decreased prostaglandin E₂ release in an ultraviolet B model. A 2026 study combining network pharmacology, cell experiments, and zebrafish models proposed protein kinase Bα, epidermal growth factor receptor, tumor necrosis factor, and other proteins as candidate regulatory nodes.
Highly connected proteins identified through network analysis reflect potentially relevant biological processes. They do not demonstrate that compounds in P. utilis seed oil directly bind to these proteins or act through a single established causal pathway.
4. Attribution of Research Evidence for Key Mechanistic Markers
Marker or Pathway | Biological Function | Evidence for P. utilis Seed Oil | Current Interpretation |
FLG, LOR, IVL, TGM1 | Keratin aggregation, cornified envelope formation, and protein cross-linking | Preliminary findings from reconstructed epidermis formulation studies | May support keratinocyte differentiation, but human studies and independent replication are still required |
CERS3 | Synthesis of ultra-long-chain ceramides | Preliminary findings from reconstructed epidermis formulation studies | Mechanistically relevant, but validation by ceramide lipidomics remains lacking |
ASAH1 | Hydrolysis of ceramides and participation in the salvage pathway | Complete direct causal evidence is lacking | Increased ASAH1 cannot be interpreted as evidence of increased ceramide levels |
FASN | De novo synthesis of palmitic acid | Evidence mainly derived from oil-cake aqueous extracts or polysaccharides | Should not be regarded as a confirmed target of P. utilis seed oil |
HMGCR | Catalysis of the rate-limiting step in cholesterol synthesis | Evidence mainly derived from oil-cake aqueous extracts | Should not be regarded as a confirmed target of P. utilis seed oil |
PPARα | Regulation of keratinocyte differentiation and lipid metabolism | Causal evidence mainly derived from P. utilis polysaccharide studies | Fatty acids may biologically modulate PPARs, but direct evidence for P. utilis seed oil is insufficient |
Claudin-1 | Maintenance of epidermal tight junctions | Evidence mainly derived from oil-cake aqueous extracts and polysaccharides | Direct validation for P. utilis seed oil is still lacking |
TJP1, Claudin-5 | Tight-junction-associated proteins | Preliminary findings from reconstructed epidermis formulation studies | TJP1 is relevant to the epidermis; Claudin-5 findings require interpretation based on cellular localization |
AKT1, EGFR, TNF | Signaling related to cell survival, repair, and inflammation | Candidate relationships proposed by network pharmacology and model experiments | Useful for subsequent validation but should not be regarded as established direct targets |
The effects of P. utilis seed oil for which evidence is currently most concentrated include surface emolliency, fatty acid supply, and preliminary modulation of keratinocyte differentiation and inflammatory responses. Stronger evidence involving FASN, HMGCR, PPARα, and Claudin-1 has primarily been obtained from water-soluble fractions of P. utilis rather than from the seed oil itself.
In addition, a multicenter, randomized, parallel-controlled study evaluated an emollient product containing P. utilis-derived ingredients during the maintenance phase of infantile atopic dermatitis. The findings suggested that continued use of the emollient during the maintenance period may improve maintenance outcomes and delay recurrence.
However, because the study evaluated a complete emollient product and the control group did not receive an otherwise identical vehicle formulation without P. utilis seed oil, the findings cannot establish the independent clinical efficacy of pure P. utilis seed oil. They also cannot directly validate specific molecular mechanisms involving PNPLA1, CERS3, ASAH1, or related targets.
5. Scope of P. utilis Seed Oil in the Care of Environmentally Damaged Skin
5.1 Skin Protection in Cold and Low-Humidity Environments
Cold temperatures, low humidity, and wind can increase cutaneous water loss and affect corneocyte maturation and tight-junction protein expression. By forming a surface oil film, P. utilis seed oil may reduce water evaporation and help relieve tightness, scaling, and roughness caused by environmental dryness.
This effect represents barrier protection under dry environmental conditions. Frostbite involves tissue freezing, microcirculatory dysfunction, ischemia, and reperfusion injury. Current evidence does not support the use of P. utilis seed oil as an ingredient for the prevention or treatment of frostbite.
5.2 Adjunctive Care After Ultraviolet-Induced Damage
In reconstructed epidermis models exposed to ultraviolet B (UVB), P. utilis seed oil has shown preliminary effects in reducing prostaglandin E₂ release and supporting the expression of barrier-related proteins.
These findings are relevant to post-exposure inflammatory modulation and barrier recovery. They do not indicate that P. utilis seed oil has established ultraviolet-absorbing properties. Formulations containing the oil that have not undergone sun protection factor and ultraviolet A protection testing should not be used as sunscreens or ultraviolet filters.
5.3 Burns and Wound Care
P. utilis seed oil has a history of traditional use in relation to skin injury, and preliminary evidence has also been obtained from cell-migration and animal repair models. However, current data remain insufficient to support its use in the treatment of acute burns, deep burns, or open wounds.
Cosmetic-grade P. utilis seed oil is more appropriately used on intact skin for dryness, post-irritation discomfort, and care of a compromised skin barrier. When blistering, exudation, tissue necrosis, or a risk of infection is present, standardized medical wound care should be provided.
6. Formulation Applications and Efficacy Evaluation of P. utilis Seed Oil
6.1 Raw-Material Quality and Oxidative Stability
P. utilis seed oil contains a relatively high proportion of unsaturated fatty acids. Its oxidative stability is influenced by the fatty acid profile, tocopherol and sterol content, extraction process, metal ions, light exposure, temperature, and contact with oxygen.
Raw-material quality evaluation should include the following parameters:
Quality Parameter | Evaluation Purpose |
Fatty acid fingerprint | Confirms the proportions of linoleic acid, oleic acid, palmitic acid, and stearic acid and assesses batch-to-batch consistency |
Acid value | Reflects triacylglycerol hydrolysis and free fatty acid levels |
Peroxide value | Evaluates primary lipid oxidation |
p-Anisidine value or total oxidation value | Evaluates secondary oxidation products, including aldehydes |
Tocopherols and phytosterols | Evaluates unsaponifiable constituents and intrinsic antioxidant capacity |
Heavy metals, pesticides, and residual solvents | Evaluates raw-material safety and process control |
Photostability, accelerated stability, and in-use stability after opening | Evaluates quality changes under actual formulation and packaging conditions |
Antioxidants, metal-ion chelators, low-oxygen manufacturing processes, and light-protective packaging with low oxygen permeability may be used to slow lipid oxidation.
6.2 Role of P. utilis Seed Oil in Biomimetic Barrier Formulations
P. utilis seed oil primarily supplies triacylglycerols and certain C16 and C18 fatty acids. It does not contain the complete combination of ceramides, cholesterol, and ultra-long-chain free fatty acids found in the stratum corneum. It is therefore more appropriately used in formulations as an emollient oil and as a source of fatty acid substrates.
A more complete barrier-repair system may include the following components:
① P. utilis seed oil: Provides an emollient film, exogenous fatty acids such as linoleic acid, and small amounts of unsaponifiable constituents;
② Ceramides: Directly replenish characteristic sphingolipids of the stratum corneum;
③ Cholesterol and free fatty acids of appropriate chain length: Support lamellar lipid organization and ordered carbon-chain packing;
④ Glycerol, amino acids, and other humectants: Increase stratum corneum hydration;
⑤ Lamellar or liquid-crystalline emulsion structures: Improve the distribution and organization of lipids on the skin surface;
⑥ An antioxidant system: Limits oxidation of unsaturated fatty acids and minor lipid constituents.
This formulation approach simultaneously addresses surface film formation, direct lipid replenishment, and endogenous epidermal metabolism. It therefore more closely reflects the physiological structure of the stratum corneum than simply increasing the concentration of P. utilis seed oil.
6.3 Efficacy Evaluation Should Distinguish Immediate Water Retention from Structural Repair
The barrier efficacy of formulations containing P. utilis seed oil can be evaluated at several levels:
1. Immediate phase: Measure TEWL, stratum corneum hydration, and skin friction shortly after application;
2. Wash-off phase: Remove the surface oil film using a standardized cleansing procedure and then reassess TEWL;
3. Continuous-use phase: Evaluate TEWL, hydration, and sensitivity-related symptoms after several weeks of use;
4. Barrier-recovery phase: Use tape stripping or a standardized surfactant challenge model to measure the rate of barrier recovery;
5. Structural phase: Assess ceramide subclasses, free fatty acid chain length, lipid order, and markers such as FLG, LOR, TGM1, and CERS3.
An immediate reduction in TEWL mainly supports an occlusive and emollient effect. Improvements that persist after wash-off, accelerated recovery following barrier disruption, and changes in lipid or protein structure provide stronger evidence of repair within the epidermis itself.
7. Classification and Research Applications of Chemicals Related to the Skin-Barrier Repair Mechanisms of Prinsepia utilis Seed Oil
Table 1. Products Related to Moisturization Assessment and Skin-Barrier Damage Models
Category | CAS No. | Aladdin Cat. No. | Product Name | Specification or Purity | Product Features and Applications |
Natural moisturizing factor-related component | 28874-51-3 | Sodium L-pyroglutamate-5-carboxylate | 50% in oil | A component of the natural moisturizing factor; used to evaluate hygroscopic water retention in the stratum corneum, skin hydration, and barrier-repair formulations | |
Polyol humectant | 56-81-5 | Glycerol | Anhydrous grade, UltraBio™, molecular biology grade, ≥99.5% (GC) | Used for hygroscopic water retention in the stratum corneum, transepidermal water loss assessment, moisturizing formulation development, and basic control experiments | |
Stratum corneum moisturizing component | 57-13-6 | Urea | UltraBio™, molecular biology grade, ≥99.5% (T) | A natural moisturizing factor-related component; used in studies of keratin hydration, dry-skin models, and stratum corneum hydration status | |
Reagent for epidermal barrier damage models | 151-21-3 | Sodium dodecyl sulfate (SDS) | Anhydrous grade, ACS, ≥99% | Used to establish surfactant-induced epidermal barrier damage models and to evaluate transepidermal water loss, inflammatory responses, and the rate of barrier recovery |
Table 2. Products Related to Fatty Acids and Phytosterols in Prinsepia utilis Seed Oil
Category | CAS No. | Aladdin Cat. No. | Product Name | Specification or Purity | Product Features and Applications |
C16 saturated fatty acid | 57-10-3 | Palmitic acid | Stearic acid ≤0.5% | One of the major fatty acids in P. utilis seed oil; used in fatty acid composition analysis and studies of fatty acid elongation and epidermal lipid synthesis | |
C16/C18 saturated fatty acid mixture | 57-11-4 | S1372596 | Stearic acid | Moligand™, C18: 40%, C16: 60% | Used to investigate C16-to-C18 saturated fatty acid ratios, lipid-membrane order, emulsion structure, and barrier-lipid systems |
C18 monounsaturated fatty acid | 112-80-1 | Oleic acid | European Pharmacopoeia (Ph. Eur.), ≥65% | One of the major fatty acids in P. utilis seed oil; used in studies of oil composition, stratum corneum lipid fluidity, skin penetration, and fatty acid metabolism | |
C18 essential polyunsaturated fatty acid | 60-33-3 | Linoleic acid | Moligand™, ≥99% (GC) | A key fatty acid in P. utilis seed oil; used in studies of linoleate-containing acylceramide synthesis, essential fatty acid deficiency, and epidermal lipid metabolism | |
C18 polyunsaturated fatty acid | 463-40-1 | α-Linolenic acid (ALA) | Moligand™, ≥99% | A minor fatty acid in P. utilis seed oil; used in studies of polyunsaturated fatty acid composition, lipid oxidation, and inflammation-related lipid metabolism | |
C22 very-long-chain saturated fatty acid | 112-85-6 | Behenic acid (docosanoic acid) | ≥99% | Used to study the effects of fatty acid chain length on lamellar lipid organization, ceramide structure, and stratum corneum barrier performance | |
C24 very-long-chain saturated fatty acid | 557-59-5 | Lignoceric acid | ≥99% (GC) | Used in studies of stratum corneum free fatty acid chain length, very-long-chain ceramide formation, and lipid order | |
C26 ultra-long-chain saturated fatty acid | 506-46-7 | Cerotic acid | ≥95% (GC) | Used in studies of ultra-long-chain fatty acid metabolism, ceramide acyl-chain composition, and the permeability barrier of the stratum corneum | |
Phytosterol | 83-46-5 | β-Sitosterol | Moligand™, from soybean, ≥96% | Used for analysis of unsaponifiable constituents in plant oils, sterol composition studies, and evaluation of sterol–lipid membrane interactions | |
Phytosterol | 474-62-4 | Campesterol | ≥65% | Used for screening the sterol composition of plant oils, studying unsaponifiable constituents, and evaluating compatibility with lipid systems | |
Phytosterol | 83-48-7 | Stigmasterol | Moligand™, ≥90% | Used for plant-oil sterol profiling, comparative sterol composition analysis, and studies of cutaneous lipid systems |
Table 3. Products Related to Core Stratum Corneum Lipids and Sphingolipid Metabolism
Category | CAS No. | Aladdin Cat. No. | Product Name | Specification or Purity | Product Features and Applications |
Natural phospholipid mixture | 8002-43-5 | Phospholipids from sunflower, non-GMO | Natural, with ≥60% phosphatidylcholine | Rich in phosphatidylcholine; used in liposomes, lamellar emulsion systems, lipid delivery, and structural studies of barrier formulations | |
Core stratum corneum lipid | 57-88-5 | C432975 | Cholesterol, from lanolin | PharmPure™, JP, BP, European Pharmacopoeia (Ph. Eur.), NF, ultrapure grade | A component of the intercellular lipid matrix of the stratum corneum; used in combined ceramide, cholesterol, and free fatty acid systems and in lipid phase-behavior studies |
Sphingolipid metabolic precursor | 123-78-4 | D-erythro-Sphingosine | Moligand™, ≥99% | A product of ceramide hydrolysis and a precursor in the salvage synthesis pathway; used in studies of sphingolipid metabolism, ceramidase activity, and ceramide quantification methods | |
Phytosphingosine | 554-62-1 | Phytosphingosine | ≥98% | Used in the synthesis of phytosphingosine-type ceramides and in studies of sphingolipid metabolism and barrier lipids | |
Sphingosine-type ceramide | 2304-81-6 | N-Stearoyl-D-erythro-sphingosine | ≥99% | A C18 ceramide research compound; used in studies of ceramide metabolism, liquid chromatography–mass spectrometry analysis, and ceramidase-related mechanisms | |
Saturated phytosphingosine-type ceramide | 34354-88-6 | N-Stearoyl phytosphingosine | ≥98% | Used in studies of ceramide lamellar membranes, stratum corneum intercellular lipids, biomimetic lipid replenishment, and barrier-repair systems | |
Unsaturated phytosphingosine-type ceramide | 178436-06-1 | Ceramide 3B | ≥95% | Used in studies of ceramide aggregation, lipid-layer construction, auxiliary emulsification, and skin-barrier formulations |
Table 4. Fatty Acid Methyl Esters and Triacylglycerols for Research Use
Category | CAS No. | Aladdin Cat. No. | Product Name | Specification or Purity | Product Features and Applications |
Saturated fatty acid methyl ester | 112-39-0 | Methyl palmitate | ≥99% (GC) | Used to verify the palmitic acid composition of P. utilis seed oil, analyze saturated fatty acid proportions, compare chromatographic retention times, and investigate raw-material batches | |
Saturated fatty acid methyl ester | 112-61-8 | Methyl stearate | ≥99% | Used to verify the stearic acid composition of P. utilis seed oil, analyze the proportion of C18 saturated fatty acids, and investigate changes in fatty acid composition before and after processing | |
Monounsaturated fatty acid methyl ester | 112-62-9 | Methyl oleate | ≥99% | Used to verify the oleic acid composition of P. utilis seed oil, analyze monounsaturated fatty acid proportions, and establish raw-material fatty acid fingerprints | |
Polyunsaturated fatty acid methyl ester | 112-63-0 | Methyl linoleate | ≥99% (GC) | Used to verify the linoleic acid composition of P. utilis seed oil, analyze essential fatty acid content, assess raw-material batch consistency, and compare composition before and after oxidation | |
Polyunsaturated fatty acid methyl ester | 301-00-8 | Methyl linolenate | ≥99% | Used to verify the α-linolenic acid composition of P. utilis seed oil, analyze low-abundance polyunsaturated fatty acids, and study oxidative stability | |
Saturated triacylglycerol | 555-44-2 | Tripalmitin | ≥98% | Used in studies of triacylglycerol composition, lipolysis, palmitic acid release, lipid crystallization, and fatty acid metabolism | |
Saturated triacylglycerol | 555-43-1 | Tristearin | ≥99% | Used in studies of saturated triacylglycerol composition, melting and crystallization, lipid-membrane structure, and lipolytic behavior | |
Monounsaturated triacylglycerol | 122-32-7 | Triolein | ≥99% | Used in studies of triacylglycerol composition, oleic acid release, lipolysis kinetics, and oxidation of unsaturated oils | |
Polyunsaturated triacylglycerol | 537-40-6 | Trilinolein | ≥98% | Used in studies of linoleate-containing triacylglycerol lipolysis, oxidative stability, linoleic acid release, and triacylglycerol-associated linoleate donation for acylceramide synthesis |
Table 5. Products Related to Mechanistic Validation of Lipid Metabolism and Formulation Stability
Category | CAS No. | Aladdin Cat. No. | Product Name | Specification or Purity | Product Features and Applications |
Acid ceramidase inhibitor | 61422-45-5 | Carmofur | ≥98% (HPLC) | Used to inhibit acid ceramidase and investigate ceramide hydrolysis, sphingosine generation, and epidermal sphingolipid turnover | |
Lipase and fatty acid synthase inhibitor | 96829-58-2 | Orlistat | Moligand™, ≥97% (HPLC) | Exhibits inhibitory activity against both lipases and fatty acid synthase; used to study endogenous fatty acid synthesis and lipolytic processes | |
Fatty acid synthase inhibitor | 191282-48-1 | C75, racemic, inhibitor | ≥98% | Used to investigate de novo fatty acid synthesis, palmitic acid production, and validation of epidermal lipid-synthesis pathways | |
Cholesterol biosynthesis pathway inhibitor | 75330-75-5 | Lovastatin | Moligand™, ≥98% | Used to inhibit hydroxymethylglutaryl-CoA reductase and investigate the effects of cholesterol synthesis on stratum corneum lipids and barrier recovery | |
Cholesterol biosynthesis pathway inhibitor | 79902-63-9 | Simvastatin | Moligand™, ≥97% (HPLC) | Used for hydroxymethylglutaryl-CoA reductase inhibition and studies of the mevalonate–cholesterol pathway | |
Mevalonate pathway supplement | 674-26-0 | DL-Mevalonolactone | ≥98% | Used to supplement the mevalonate pathway after statin-mediated inhibition and in rescue experiments involving the cholesterol biosynthesis pathway | |
Peroxisome proliferator-activated receptor-α agonist | 50892-23-4 | WY-14643, pirinixic acid | Moligand™, ≥98% | Used to study fatty acid sensing, keratinocyte differentiation, and peroxisome proliferator-activated receptor-α-dependent pathways | |
Peroxisome proliferator-activated receptor-α antagonist | 880635-03-0 | GW6471 | ≥98% | Used to block peroxisome proliferator-activated receptor-α and validate its involvement in lipid metabolism, keratinocyte differentiation, and tight-junction-related effects | |
Natural lipid-soluble antioxidant | 59-02-9 | D-α-Tocopherol | Moligand™, ≥97% (GC) | Used to inhibit the oxidation of unsaturated lipids, evaluate the oxidative stability of P. utilis seed oil, and construct oil-phase antioxidant systems | |
Lipid-soluble antioxidant | 137-66-6 | L-Ascorbyl palmitate | PharmPure™, USP | Used for oil-phase free-radical scavenging, control of lipid peroxidation, and formulation-stability studies involving P. utilis seed oil | |
Phenolic antioxidant | 128-37-0 | 2,6-Di-tert-butyl-p-cresol, BHT | Ultrapure grade, ≥99.5% (GC) | Used in accelerated oxidation studies of P. utilis seed oil, storage-stability studies, and comparative evaluation of antioxidant systems | |
Phenolic antioxidant | 1948-33-0 | Tert-butylhydroquinone, TBHQ | ≥98% | Used for the antioxidant protection of polyunsaturated plant oils, peroxide-value control, and oil-storage stability studies | |
Metal-ion chelator | 139-33-3 | Disodium ethylenediaminetetraacetate | ≥99% | Used to chelate pro-oxidant metal ions such as iron and copper, reduce metal-catalyzed lipid oxidation, and improve the stability of emulsion systems |
Note: The products listed above are representative Aladdin products related to scientific research and formulation studies. Additional product specifications, grades, and certificates of analysis may be searched on the Aladdin website using the product name, CAS number, or catalog number.
References
[1] Wei H, Lü X, Xie Y, et al. Analysis of lipid components in Prinsepia utilis seed oil by ultra-performance liquid chromatography–time-of-flight tandem mass spectrometry[J]. Chinese Journal of Oil Crop Sciences, 2019, 41(6): 947-955. DOI: 10.19802/j.issn.1007-9084.2019144. [In Chinese]
[2] Chauhan K, Bhalla P, Chitme HR, et al. Exploring the therapeutic potential of Prinsepia utilis Royle seed oil: A comprehensive study on chemical composition, physicochemical properties, anti-inflammatory, and analgesic activities[J]. Journal of Ethnopharmacology, 2024, 319: 117312. DOI: 10.1016/j.jep.2023.117312.
[3] Kewlani P, Tewari DC, Singh L, et al. Saturated and polyunsaturated fatty acids rich populations of Prinsepia utilis Royle in Western Himalaya[J]. Journal of Oleo Science, 2022, 71(4): 481-491. DOI: 10.5650/jos.ess21262.
[4] Li C, He R, Yin X, et al. Bioactive compounds and related food-medicine homology potential of Prinsepia utilis seed oil[J]. Molecules, 2026, 31(10): 1700. DOI: 10.3390/molecules31101700.
[5] Feingold KR, Elias PM. The role of ceramides in the disruption of the cutaneous permeability barrier, a common manifestation of skin disorders[J]. Journal of Lipid Research, 2024, 65(8): 100593. DOI: 10.1016/j.jlr.2024.100593.
[6] Wertz PW. Linoleate-containing acylglucosylceramide, acylceramide, and events associated with formation of the epidermal permeability barrier[J]. Skin Pharmacology and Physiology, 2023, 36(5): 225-232. DOI: 10.1159/000535049.
[7] Ohno Y, Kamiyama N, Nakamichi S, et al. PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide[J]. Nature Communications, 2017, 8: 14610. DOI: 10.1038/ncomms14610.
[8] Schild J, Kalvodová A, Zbytovská J, et al. The role of ceramides in skin barrier function and the importance of their correct formulation for skincare applications[J]. International Journal of Cosmetic Science, 2024, 46(4): 526-543. DOI: 10.1111/ics.12972.
[9] Wang B, Wang F, Gao H. Prinsepia utilis Royle oil extract improve skin barrier on reconstructed skin model[J]. International Journal of Nursing and Health Care Research, 2022, 5: 1363. DOI: 10.29011/2688-9501.101363.
[10] Tu Y, An R, Gu H, et al. The water extracts from the oil cakes of Prinsepia utilis repair the epidermal barrier via up-regulating corneocyte envelope-proteins, lipid synthases, and tight junction proteins[J]. Journal of Ethnopharmacology, 2024, 330: 118194. DOI: 10.1016/j.jep.2024.118194.
[11] Wang B, Wang F, Qu L, et al. Prinsepia utilis Royle polysaccharides promote skin barrier repair through the Claudin family[J]. Skin Research and Technology, 2024, 30(7): e13848. DOI: 10.1111/srt.13848.
[12] Tu Y, Li N, Liu HY, et al. Polysaccharide from Prinsepia utilis Royle maintains the skin barrier by mediating differentiation, lipid metabolism and tight junction of keratinocyte[J]. Scientific Reports, 2025, 15: 20470. DOI: 10.1038/s41598-025-01960-w.
[13] Takada M, Sashikawa-Kimura M, Ohno Y, et al. Acid ceramidase overactivity drives ceramide loss, leading to atopic dry skin and Th2-skewed immune polarization[J]. The Journal of Pathology, 2026, 269: 232-247. DOI: 10.1002/path.70050.
[14] Yuan D, He R, Tian J. Exploring the soothing and reparative effects of Prinsepia utilis Royle oil based on network pharmacology and experimental validation[J]. Journal of Dermatologic Science and Cosmetic Technology, 2026, 3(2): 100150. DOI: 10.1016/j.jdsct.2026.100150.
[15] Furuse M, Hata M, Furuse K, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: A lesson from Claudin-1-deficient mice[J]. Journal of Cell Biology, 2002, 156(6): 1099-1111. DOI: 10.1083/jcb.200110122.
[16] Chen G, Liu F, Guo Y, Nie X. Physicochemical properties of Prinsepia utilis fruit and oil and the fatty acid composition of the oil[J]. Cereals & Oils, 2020, 33(1): 69-71. [In Chinese]
[17] Tu Y, Gu H, Li N, et al. Effects of Prinsepia utilis seed oil on ceramide synthesis and ceramidase expression[J]. Chinese Journal of Dermatology, 2012, 45(10): 718-722. DOI: 10.3760/cma.j.issn.0412-4030.2012.10.012. [In Chinese]
[18] Wang S, Wang L, Li P, et al. The improvement of infantile atopic dermatitis during the maintenance period: A multicenter, randomized, parallel controlled clinical study of emollients in Prinsepia utilis Royle[J]. Dermatologic Therapy, 2020, 33(2): e13153. DOI: 10.1111/dth.13153.
For additional related articles, please see below.
Applicability Comparison of Vitronectin, Laminin and Fibronectin in Cell Culture Coating Systems
Antibody simulation experiments based on the framework of fibronectin type III structural domains
Ferulic Acid: Structural Features, Preparation Routes, and Key Points for Research Applications
Role of Sphingolipid Metabolic Remodeling in Apoptotic and Inflammatory Signaling
How to decipher the whitening code?
Niacin (Vitamin B3): Structural Features, Metabolic Roles, and Application Landscape
The "Six Key Checkpoints" of Skin Lightening
Tyrosinase: a key regulatory enzyme in melanin synthesis and its biological and applied significance
Enzymatic Hydroxylation Mechanism of Salicylate Conversion to Catechol
危险品化学品经营许可证(带存储)